4 April 2023 - Shionogi today announced that the US FDA has granted fast track designation for their investigational COVID-19 ...
30 March 2023 - Renovion announced today that the US FDA has granted fast track designation to ARINA-1 for the prevention ...
29 March 2023 - EpicentRx announced today that the US FDA granted fast track designation to RRx-001, a direct NLRP3 inhibitor ...
21 March 2023 - Prestige Biopharma has received fast track designation from the US FDA for PBP1510 (ulenistamab), in the ...
20 March 2023 - Arrowhead Pharmaceuticals today announced the US FDA has granted fast track designation to ARO-APOC3 for reducing ...
17 March 2023 - Prestige Biopharma said on Thursday that its new pancreatic cancer antibody drug candidate, PBP1510, (ulenistamab), was ...
6 March 2023 - Ikena Oncology today announced that the US FDA has granted fast track designation for IK-175, the ...
21 February 2023 - Icosavax today announced the US FDA has granted fast track designation for IVX-A12, a bivalent respiratory syncytial ...
21 February 2023 - Taldefgrobep alfa, a myostatin-targeting biologic investigational agent, in Phase 3 development to increase muscle mass for ...
14 February 2023 - Kinnate Biopharma today announced that the US FDA has granted fast track designation for Kinnate’s investigational ...
12 February 2023 - IASO Biotherapeutics today announced that the US FDA has granted both regenerative medicine advanced therapy designation ...
6 February 2023 - Endogena Therapeutics announced today that the US FDA has designated the investigation of EA-2353 for the treatment ...
31 January 2023 - Granted fast track designation by US FDA for the treatment of relapsed/refractory non-Hodgkin lymphoma of B cell ...
31 January 2023 - If approved, olezarsen would be the first approved treatment for familial chylomicronaemia syndrome in the US. ...
31 January 2023 - Reneo Pharmaceuticals today announced that the US FDA has granted mavodelpar (REN001) fast track designation for long ...